News

Kick TB Campaign Expands to Brazil

The Kick TB Campaign is a unique project that uses football (soccer), the World’s most popular sport, to educate and engage young people in the effort to stop the spread of tuberculosis. First inaugurated in South Africa during the 2010 World Cup, Kick TB has expanded to Brazil, the host country of the 2014 World Cup. The goal of Kick TB is to enlist children as “health agents” by teaching them about TB symptoms, diagnosis, prevention, and treatment. In doing so, Kick TB aims to not only raise awareness about tuberculosis, but also combat the stigma surrounding the disease. For more information about the Kick TB Campaign in Brazil see the following article Kick TB Brazil_news.

Related Links

Kick TB Campaign Website

WGND Blog Post: Kick TB Campaign: Scoring big in South Africa and Beyond

WGND Blog Post: Kick TB!

About Kick TB Brazil

Five thousand balls were produced with TB symptoms and prevention messages, to be distributed and used for especial activities in different schools from strategic areas of Sao Paolo city. In addition, students, teachers and health professionals were sensitized to the different aspects of the disease such as symptoms, prevention, diagnosis and treatment, as well as social aspects like fighting stigma and prejudice, the importance to follow the treatment until completion and the support to TB patients.

The next step will be the delivery of the Health Passports to students. Through this tool, students will be able to analyze if TB symptoms are present in their families, acting as “health agents”, spreading their TB knowledge and identifying people who might have TB. After filling in the passport, it shall be returned to the teacher who will forward to health professionals. They will screen the symptomatic to the asymptomatic homes and schedule a visit for further orientation for those who are presented with TB signs.

A Monitoring and Evaluation plan is under development in order to measure the impact of the project, and based on the evidences, spread to the rest of the country.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...